ENCY had a big day on Thursday, trading up over 16% to close the regular session at $4.45. Volume was heavy, with almost 8 million shares of the stock changing hands, compared to a normal daily average volume of just over 3 million shares traded. The stock was up after the company said that it had submitted a complete response for its pulmonary hypertension drug, and that it expects to hear within 30 days if it will be accepted. The stock could use the good news, as it is trading perilously close to its 52 week low of $3.29, and far below its 52 week high of $13.29.
Sorry, the comment form is closed at this time.